Penn Davis McFarland’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3M Sell
2,595
-100
-4% -$118K 0.26% 42
2026
Q2
$3.23M Hold
2,695
– – 0.29% 42
2026
Q1
$2.48M Sell
2,695
-55
-2% -$55.8K 0.24% 48
2025
Q4
$2.96M Hold
2,750
– – 0.28% 44
2025
Q3
$2.1M Hold
2,750
– – 0.22% 48
2025
Q2
$2.14M Hold
2,750
– – 0.24% 48
2025
Q1
$2.27M Hold
2,750
– – 0.27% 47
2024
Q4
$2.12M Buy
2,750
+485
+21% +$402K 0.23% 49
2024
Q3
$2.01M Buy
+2,265
New +$2.04M 0.23% 50

Other funds holding LLY

Penn Davis McFarland's LLY Position: Q3 2026 in Review

Penn Davis McFarland reduced its Eli Lilly (LLY) stake by 3.7% in Q3 2026, selling an estimated $118K and leaving 2,595 shares worth $3M. The position accounts for 0.26% of the portfolio, ranked #42.

Penn Davis McFarland first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.23M in Q2 2026. 2,535 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Penn Davis McFarland held 2,595 shares of Eli Lilly worth $3M as of Q3 2026.
  • Penn Davis McFarland sold 100 Eli Lilly shares in Q3 2026, an estimated $118K.
  • Eli Lilly made up 0.26% of Penn Davis McFarland's portfolio in Q3 2026, its #42 holding.
  • Penn Davis McFarland first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
  • Penn Davis McFarland's Eli Lilly position peaked at $3.23M in Q2 2026.
  • 2,535 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Penn Davis McFarland's 13F filing for Q3 2026, filed 23 Oct 2026.